INTRODUCTION Patients with moderate-to-severe atopic dermatitis (AD) may need continuous therapy to control disease and minimize flares.1 An important consideration when using long-term therapy is to use the lowest possible drug dose to maintain efficacy while reducing the risk of adverse events (AEs).1, 2 Dosing flexibility is necessary to treat patients according to their individual disease course.
A. Blauvelt
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with A.
Contact A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack